Xinjiang Bai Hua Cun Pharma Tech Co Ltd
SSE:600721
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
|
Walt Disney Co
NYSE:DIS
|
US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
Xinjiang Bai Hua Cun Pharma Tech Co Ltd
Intangible Assets
Xinjiang Bai Hua Cun Pharma Tech Co Ltd
Intangible Assets Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Intangible Assets | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
|
Xinjiang Bai Hua Cun Pharma Tech Co Ltd
SSE:600721
|
Intangible Assets
¥43.8m
|
CAGR 3-Years
54%
|
CAGR 5-Years
28%
|
CAGR 10-Years
-22%
|
|
|
I
|
Inner Mongolia BaoTou Steel Union Co Ltd
SSE:600010
|
Intangible Assets
¥2.2B
|
CAGR 3-Years
-6%
|
CAGR 5-Years
-5%
|
CAGR 10-Years
1%
|
|
|
Baoshan Iron & Steel Co Ltd
SSE:600019
|
Intangible Assets
¥11.5B
|
CAGR 3-Years
-2%
|
CAGR 5-Years
0%
|
CAGR 10-Years
3%
|
|
|
W
|
Western Superconducting Technologies Co Ltd
SSE:688122
|
Intangible Assets
¥319m
|
CAGR 3-Years
21%
|
CAGR 5-Years
13%
|
CAGR 10-Years
N/A
|
|
|
C
|
CITIC Pacific Special Steel Group Co Ltd
SZSE:000708
|
Intangible Assets
¥7.2B
|
CAGR 3-Years
19%
|
CAGR 5-Years
12%
|
CAGR 10-Years
79%
|
|
|
Inner Mongolia Dazhong Mining Co Ltd
SZSE:001203
|
Intangible Assets
¥7.4B
|
CAGR 3-Years
37%
|
CAGR 5-Years
20%
|
CAGR 10-Years
N/A
|
|
Xinjiang Bai Hua Cun Pharma Tech Co Ltd
Glance View
Xinjiang Baihuacun Pharam Tech Co., Ltd. provides medical research and development services as a contract research organization (CRO). The company is headquartered in Urumqi, Xinjiang and currently employs 722 full-time employees. The firm's main business is the research and development, registration and application of small molecule chemicals and the development of peptide drugs. The firm is engaged in the early discovery and screening of new drugs, drug clinical trials, biological sample analysis, medicine testing services, active pharmaceutical ingredient (API) and intermediate supply. The firm is also engaged in leasing and property services. The firm mainly conducts business within the domestic market.
See Also
What is Xinjiang Bai Hua Cun Pharma Tech Co Ltd's Intangible Assets?
Intangible Assets
43.8m
CNY
Based on the financial report for Sep 30, 2025, Xinjiang Bai Hua Cun Pharma Tech Co Ltd's Intangible Assets amounts to 43.8m CNY.
What is Xinjiang Bai Hua Cun Pharma Tech Co Ltd's Intangible Assets growth rate?
Intangible Assets CAGR 10Y
-22%
Over the last year, the Intangible Assets growth was 46%. The average annual Intangible Assets growth rates for Xinjiang Bai Hua Cun Pharma Tech Co Ltd have been 54% over the past three years , 28% over the past five years , and -22% over the past ten years .
